Alcon: Eye Diseases trials
The registry lists 12 Eye Diseases studies with Alcon as lead sponsor. 0 are open to participants now and 3 have results posted.
Phase 1 1Phase 2 4Phase 3 1No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Phase 2b Study Evaluating the Safety and Efficacy of AR-15512 Ophthalmic Solution for the Treatment of Dry Eye DiseaseCompletedNCT04498182Phase 2Results posted
- Comparison Between iLux and LipiFlow in the Treatment of Meibomian Gland Dysfunction (MGD): A 12-month, Multicenter StudyCompletedNCT03956225Not applicableResults posted
- Evaluation of Anti-Inflammatory Treatment in Dry Eye PatientsCompletedNCT01276223Phase 2Results posted
- Evaluation of Reflex Tear ProductionTerminatedNCT06565624Not applicable
- Evaluation of Safety and Tolerability of Investigational Ocular LubricantsCompletedNCT05888519Not applicable
- Study Evaluating Techniques for Measuring Tear ProductionCompletedNCT05497479Phase 1
- Systane Complete Multi-symptom ReliefCompletedNCT05056155Not applicable
- Evaluation of Comfort in Subjects With Moderate Dry Eye DiseaseCompletedNCT04830956Not applicable
- Study of Efficacy and Tolerability of SYSTANE Complete in Patients With Dry Eye DiseaseCompletedNCT03492541Not applicable
- Clinical Pharmacological Study of AL-43546 Ophthalmic Product in Subjects With Shortened Tear Film Break Up TimeCompletedNCT00760045Phase 2
- Next Generation Ophthalmic Irrigating Solution Posterior Segment StudyCompletedNCT00333203Phase 3
- Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) ElevationCompletedNCT00315640Phase 2